Hot Stock Picks for Wednesday 07-27-2011
MYRX - Myriad Pharmaceuticals, a biotechnology company is developing small molecule drugs for the treatment of cancer. The company’s product pipeline includes clinical and pre-clinical product candidates with mechanisms of action and novel chemical structures.
Its product candidates in clinical development include Azixa (MPC-6827), which is under Phase II clinical trial for the treatment of metastatic melanoma. In addition the company has a strong pipe line of drugs under development. Very Attractive, must be on your list.
Get Alerts that MakeMoney!® Everything else:HOTair©
No comments:
Post a Comment